Increased urinary L-histidine in patients with asthma COPD overlap: a pilot study
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Oh, Jee Youn | - |
dc.contributor.author | Lee, Young Seok | - |
dc.contributor.author | Min, Kyung Hoon | - |
dc.contributor.author | Hur, Gyu Young | - |
dc.contributor.author | Lee, Sung Yong | - |
dc.contributor.author | Kang, Kyung Ho | - |
dc.contributor.author | Rhee, Chin Kook | - |
dc.contributor.author | Park, Seoung Ju | - |
dc.contributor.author | Khan, Adnan | - |
dc.contributor.author | Na, Jinhyuk | - |
dc.contributor.author | Park, Youngja H. | - |
dc.contributor.author | Shim, Jae Jeong | - |
dc.date.accessioned | 2021-09-02T21:20:58Z | - |
dc.date.available | 2021-09-02T21:20:58Z | - |
dc.date.created | 2021-06-16 | - |
dc.date.issued | 2018 | - |
dc.identifier.issn | 1176-9106 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/80998 | - |
dc.description.abstract | Purpose: Asthma-COPD overlap (ACO) is heterogeneous in nature and requires a unified diagnostic approach. We investigated the urinary levels of L-histidine, a precursor of histamine related to inflammatory responses, as a new candidate biomarker for diagnosing this condition. Patients and methods: We performed a prospective multicenter cohort study with retrospective analysis of 107 patients, who were divided into three groups: asthma, COPD, and ACO, according to the Spanish guidelines algorithm. Urinary L-histidine levels were measured using liquid chromatography-mass spectrometry. High-resolution metabolomic analysis, coupled with liquid chromatography-mass spectrometry and followed by multivariate statistical analysis, was performed on urine samples to discriminate between the metabolic profiles of the groups. Results: Urinary L-histidine levels were significantly higher in patients with ACO than in those with asthma or COPD, but the subgroups of ACO, classified according to disease origin, did not differ significantly. High urinary L-histidine level was a significant factor for the diagnosis of ACO even after adjusting for age, sex, and smoking amount. Among patients with airflow obstruction, the urinary L-histidine levels were elevated in patients with a documented history of asthma before the age of 40 years or bronchodilator responsiveness >= 400 mL; bronchodilator responsiveness >= 200 mL of forced expiratory volume in 1 second and exceeding baseline values by 12% on two or more visits; blood eosinophil count >= 300 cells-mm(-3); and frequent exacerbations (P < 0.05). Conclusion: Urinary L-histidine could be a potential biomarker for ACO, regardless of the diversity of diagnostic definitions used. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | DOVE MEDICAL PRESS LTD | - |
dc.subject | OBSTRUCTIVE PULMONARY-DISEASE | - |
dc.subject | INHALED CORTICOSTEROIDS | - |
dc.subject | PRECISION MEDICINE | - |
dc.subject | DENDRITIC CELLS | - |
dc.subject | HISTAMINE | - |
dc.subject | EXACERBATION | - |
dc.subject | METABOLOMICS | - |
dc.subject | RISK | - |
dc.title | Increased urinary L-histidine in patients with asthma COPD overlap: a pilot study | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Oh, Jee Youn | - |
dc.contributor.affiliatedAuthor | Lee, Young Seok | - |
dc.contributor.affiliatedAuthor | Min, Kyung Hoon | - |
dc.contributor.affiliatedAuthor | Hur, Gyu Young | - |
dc.contributor.affiliatedAuthor | Kang, Kyung Ho | - |
dc.contributor.affiliatedAuthor | Park, Youngja H. | - |
dc.contributor.affiliatedAuthor | Shim, Jae Jeong | - |
dc.identifier.doi | 10.2147/COPD.S163189 | - |
dc.identifier.scopusid | 2-s2.0-85048289936 | - |
dc.identifier.wosid | 000434032400002 | - |
dc.identifier.bibliographicCitation | INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, v.13, pp.1809 - 1818 | - |
dc.relation.isPartOf | INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE | - |
dc.citation.title | INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE | - |
dc.citation.volume | 13 | - |
dc.citation.startPage | 1809 | - |
dc.citation.endPage | 1818 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Respiratory System | - |
dc.relation.journalWebOfScienceCategory | Respiratory System | - |
dc.subject.keywordPlus | OBSTRUCTIVE PULMONARY-DISEASE | - |
dc.subject.keywordPlus | INHALED CORTICOSTEROIDS | - |
dc.subject.keywordPlus | PRECISION MEDICINE | - |
dc.subject.keywordPlus | DENDRITIC CELLS | - |
dc.subject.keywordPlus | HISTAMINE | - |
dc.subject.keywordPlus | EXACERBATION | - |
dc.subject.keywordPlus | METABOLOMICS | - |
dc.subject.keywordPlus | RISK | - |
dc.subject.keywordAuthor | asthma | - |
dc.subject.keywordAuthor | COPD | - |
dc.subject.keywordAuthor | ACO | - |
dc.subject.keywordAuthor | urinary L-histidine | - |
dc.subject.keywordAuthor | metabolomics | - |
dc.subject.keywordAuthor | inhaled corticosteroid | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.